Join Growin Stock Community!

中化控股3716.TW Overview

TW StockBiotech. & Medical
(No presentation for 3716)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

中化控股（3716）Overall Performance

中化控股（3716）AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

中化控股（3716） PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

中化控股（3716）Key Information

中化控股（3716）Profile

中化控股（3716）FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
2.82
PE Ratio (TTM)
12.07
Forward PE
-
PS Ratio (TTM)
0.47
PB Ratio
0.68
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
38.32%
Net Margin
3.86%
Revenue Growth (YoY)
-%
Profit Growth (YoY)
-%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
2.82
PE Ratio (TTM)
12.07
Forward PE
-
PS Ratio (TTM)
0.47
PB Ratio
0.68
Price-to-FCF
-
Gross Margin
38.32%
Net Margin
3.86%
Revenue Growth (YoY)
-%
Profit Growth (YoY)
-%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%
default symbol

3716

中化控股

34.00D

-0.29%

(-0.00)

  • When is 3716's latest earnings report released?

    The most recent financial report for 中化控股 (3716) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 3716's short-term business performance and financial health. For the latest updates on 3716's earnings releases, visit this page regularly.

  • Where does 3716 fall in the P/E River chart?

    According to historical valuation range analysis, 中化控股 (3716)'s current price-to-earnings (P/E) ratio is 13.37, placing it in the Overvalued zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning optimistic. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

  • How much cash does 3716 have?

    At the end of the period, 中化控股 (3716) held Total Cash and Cash Equivalents of 678.64M, accounting for 0.05 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 3716 go with three margins increasing?

    In the latest report, 中化控股 (3716) achieved the “three margins increasing” benchmark, with a gross margin of 38.35%%, operating margin of 4.39%%, and net margin of 3.47%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 3716's profit trajectory and future growth potential.